Stock 6600 SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company SciClone Pharmaceuticals (Holdings) Limited

Equities

6600

KYG4271B1023

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:16 2024-04-24 am EDT 		5-day change 1st Jan Change
17.98 HKD -0.11% Intraday chart for SciClone Pharmaceuticals (Holdings) Limited -0.11% +29.17%
Apr. 18 Sciclone Pharmaceuticals to Dispatch Privatization Documents by May 31 MT
Apr. 01 SciClone Pharmaceuticals Logs 31% Increase in 2023 Profit MT

Business Summary

SciClone Pharmaceuticals Holdings Ltd is a China-based biopharmaceutical company principally engaged in developing and commercializing a portfolio of marketed products as well as pipeline with potential in its focused therapeutic areas including oncology and severe infection. The Company primarily engages in the sales of its proprietary product, Zadaxin, its in-licensed products and promotion products on behalf of its business partners in China.

Number of employees: 860

Sales per Business

HKD in Million2021Weight2022Weight Delta
Pharmaceuticals
100.0 %
3,035 100.0 % 3,198 100.0 % +5.35%

Sales per region

HKD in Million2021Weight2022Weight Delta
China
97.0 %
2,967 97.8 % 3,103 97.0 % +4.58%
Others
3.0 %
68 2.2 % 94 3.0 % +38.74%

Managers

Managers TitleAgeSince
Hong Zhao CEO
 Chief Executive Officer 60 20-05-31
Rong Rong Pan DFI
 Director of Finance/CFO 46 -
Mao Li CTO
 Chief Tech/Sci/R&D Officer 66 22-06-12
Lian Zong Wu PRN
 Corporate Officer/Principal 50 -
Min Jia PRN
 Corporate Officer/Principal 53 -
Yan Song Chang PRN
 Corporate Officer/Principal 56 -
Ming Xiang Wu PRN
 Corporate Officer/Principal 58 -
Chih Wen Shao PRN
 Corporate Officer/Principal 61 -
Lingyu Zhu PRN
 Corporate Officer/Principal 54 -

Members of the board

Members of the board TitleAgeSince
Daniel Vasella BRD
 Director/Board Member 70 20-05-31
Hong Zhao CEO
 Chief Executive Officer 60 20-05-31
Zhen Fu Li CHM
 Chairman 59 20-05-31
Guo En Liu BRD
 Director/Board Member 67 -
Wendy Hayes BRD
 Director/Board Member 54 21-02-28
Yushao Gu BRD
 Director/Board Member 55 -
Rong Rong Pan DFI
 Director of Finance/CFO 46 -
Ping Chen BRD
 Director/Board Member 66 -
Hai Xia Wang BRD
 Director/Board Member 50 21-06-15
Shirley Yi-Hsien Lin BRD
 Director/Board Member 42 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 627,646,692 339,329,011 ( 54.06 %) 0 54.06 %

Shareholders

NameEquities%Valuation
CDH Investments Management (Hong Kong) Ltd.
9.953 %
62,436,790 9.953 % 128 M $
GL Capital Group
9.850 %
61,785,690 9.850 % 127 M $
BANK OF CHINA LIMITED
7.560 %
47,426,727 7.560 % 97 M $
Jinyao Development Co. Ltd.
5.304 %
33,273,000 5.304 % 68 M $
Ascendent Capital Partners (China) Ltd.
4.749 %
29,791,537 4.749 % 61 M $
Juli Information Consulting (Beijing) Co. Ltd.
1.910 %
11,979,690 1.910 % 25 M $
Zhong Geng Fund Management Co. , Ltd.
1.686 %
10,578,500 1.686 % 22 M $
Wei Hang Zhu
0.9969 %
6,253,820 0.9969 % 13 M $
Rong Rong Pan
0.5604 %
3,515,667 0.5604 % 7 M $
Zhong Ou Asset Management Co., Ltd
0.3655 %
2,292,500 0.3655 % 5 M $

Company contact information

SciClone Pharmaceuticals (Holdings) Ltd.

22/F, Central Plaza 381 Middle Huaihai Road

200020, Shanghai

+

http://www.sciclone.com
address SciClone Pharmaceuticals (Holdings) Limited(6600)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per region

Ratings for SciClone Pharmaceuticals (Holdings) Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
16.63 CNY
Average target price
16.5 CNY
Spread / Average Target
-0.82%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
SCICLONE PHARMACEUTICALS (HOLDINGS) LIMITED Stock SciClone Pharmaceuticals (Holdings) Limited
+29.17% 1.4B
CSL LIMITED Stock CSL Limited
-2.86% 87.37B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.95% 41.01B
BIOGEN INC. Stock Biogen Inc.
-21.94% 28.08B
UCB Stock UCB
+53.11% 24.72B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-5.41% 17.47B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-44.23% 11.69B
INCYTE CORPORATION Stock Incyte Corporation
-17.60% 11.6B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-13.96% 11.56B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
-0.22% 8.44B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 6600 Stock
  4. Company SciClone Pharmaceuticals (Holdings) Limited